Stock HALO HALOZYME THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Halozyme Therapeutics, Inc.

Equities

HALO

US40637H1095

Real-time Estimate Cboe BZX
Other stock markets
 19:44:06 29/04/2024 BST 		5-day change 1st Jan Change
38.9 USD +0.86% Intraday chart for Halozyme Therapeutics, Inc. +0.74% +5.51%
04-25 Halozyme Therapeutics, Inc. Announces the Election of Mahesh Krishnan, M.D. to its Board of Directors CI
04-18 Halozyme Therapeutics Insider Sold Shares Worth $768,390, According to a Recent SEC Filing MT

Chart calendar Halozyme Therapeutics, Inc.

e9d0f3b.xoIAbc6Xjx-Qe6gfj8nHghTY63KwC8a6saCeQ3m5OTQ.oMVXXIP1v0f-PuJNvPmJx3bomxeFeIjo45XPJgr7Q2GNtUIMp9LOWPkcnA~a54b52057d95ab403eba3812a7d0e6b0

Upcoming events on Halozyme Therapeutics, Inc.

07/05/2024 21:01 Q1 2024 Earnings Release
07/05/2024 21:30 Q1 2024 Earnings Call
05/08/2024 Q2 2024 Earnings Release (Projected)
03/11/2024 Q3 2024 Earnings Release (Projected)
24/02/2025 Q4 2024 Earnings Release (Projected)
12/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Halozyme Therapeutics, Inc.

25/04/2024 20:00 Annual General Meeting
13/03/2024 14:45 Barclays Global Healthcare Conference
12/03/2024 19:00 Leerink Partners Global Biopharma Conference
05/03/2024 19:50 TD Cowen Health Care Conference
20/02/2024 21:30 Q4 2023 Earnings Call
20/02/2024 21:01 Q4 2023 Earnings Release
17/01/2024 13:30 Business Update Call
29/11/2023 17:30 Evercore ISI HealthCONx Conference
29/11/2023 13:00 Piper Sandler Healthcare Conference
06/11/2023 21:30 Q3 2023 Earnings Call
06/11/2023 21:01 Q3 2023 Earnings Release
17/10/2023 15:35 Partnership Opportunities in Drug Delivery Conference
13/09/2023 18:25 Baird Global Healthcare Conference
12/09/2023 15:50 Morgan Stanley Global Healthcare Conference
11/09/2023 14:30 H.C. Wainwright Global Investment Conference
07/09/2023 13:00 Wells Fargo Healthcare Conference
08/08/2023 21:30 Q2 2023 Earnings Call
08/08/2023 21:01 Q2 2023 Earnings Release
13/06/2023 16:00 Goldman Sachs Global Healthcare Conference
22/05/2023 Benchmark Healthcare House Call Virtual Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		196
197
-0.69%		268
265
0.89%		443
442
0.4%		660
672
-1.74%		829
830
-0.13%
954

EBITDA
Million USD		Released
Forecast
Spread 		-63,5
-56,4
-12.67%		148
144
2.66%		279
278
0.26%		315
339
-7.01%		426
414
3.04%
544

EBIT
Million USD		Released
Forecast
Spread 		-67,6
-60,2
-12.29%		144
148
-2.83%		276
276
-0.04%		268
286
-6.39%		338
344
-1.85%
475

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-72,3
-64,1
-12.79%		129
135
-4.33%		249
250
-0.74%		249
229
8.89%		348
349
-0.08%
472

Net income
Million USD		Released
Forecast
Spread 		-72,2
-63,8
-13.27%		129
132
-2.57%		403
392
2.8%		202
183
10.35%		282
279
0.92%
370

EPS
USD		Released
Forecast
Spread 		-0,50
-0,44
-14.43%		0,91
0,93
-2.4%		2,74
2,68
2.07%		1,44
1,32
9.33%		2,10
2,07
1.29%
3,02

Announcement Date24/02/2023/02/2122/02/2221/02/2320/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		102
99,7
2.32%		117
129
-8.74%		152
156
-2.33%		209
191
9.31%		181
192
-5.5%		162
176
-7.62%		221
200
10.55%		216
216
-0.04%		230
231
-0.48%
201


208


253


292


243

EBITDA
Million USD		Released
Forecast
Spread 		57,3
60,0
-4.49%		81,2
90,0
-9.79%		40,8


85,3
105
-18.76%		79,5
98,0
-18.93%		74,5
83,0
-10.2%		115
108
6.38%		115
119
-3.18%		122
126
-3.48%
116


112


144


190




EBIT
Million USD		Released
Forecast
Spread 		56,5
58,3
-3.11%		75,7
85,7
-11.65%		34,1
88,9
-61.68%		83,3
79,1
5.29%		74,5
65,7
13.47%		53,8
68,5
-21.44%		94,5
87,4
8.04%		88,3
94,0
-6.07%		101
109
-7.05%
90,8


94,1


135


155


145

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		54,8
55,9
-1.96%		74,4
80,5
-7.58%		30,0
88,2
-65.97%		73,7
64,5
14.36%		70,8
48,5
46.02%		52,2
57,6
-9.38%		93,2
83,7
11.26%		102
88,6
14.89%		101
104
-2.82%
93,3


92,8


133


155


141

Net income
Million USD		Released
Forecast
Spread 		66,8
55,0
21.34%		60,1
63,6
-5.52%		22,7
67,9
-66.59%		61,6
48,2
27.92%		57,7
36,0
60.34%		39,6
43,3
-8.56%		74,8
65,6
13.95%		81,8
70,5
16.03%		85,4
84,8
0.68%
72,0


71,7


106


126


113

EPS
USD		Released
Forecast
Spread 		0,46
0,38
20.26%		0,43
0,46
-6.52%		0,16
0,47
-65.59%		0,44
0,36
21.66%		0,42
0,28
49.24%		0,29
0,32
-9.85%		0,57
0,47
20.91%		0,61
0,52
18.28%		0,65
0,64
1.04%
0,59


0,61


0,86


0,99


0,94

Announcement Date22/02/2210/05/2209/08/2208/11/2221/02/2309/05/2308/08/2306/11/2320/02/24-----

Upcoming sector events for Halozyme Therapeutics, Inc.

29/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
29/04/2024 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
30/04/2024 21:05 EXELIXIS, INC.: Q1 2024 Earnings Release
30/04/2024 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
30/04/2024 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 12:00 NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release
More events

Past sector events for Halozyme Therapeutics, Inc.

Today HITGEN INC.: Q1 2024 Earnings Release (Projected)
Today CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
25/04/2024 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
25/04/2024 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
25/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
25/04/2024 REMEGEN CO., LTD.: Q1 2024 Earnings Release
25/04/2024 21:05 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 11:30 SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. HALO Stock
  4. Calendar Halozyme Therapeutics, Inc.